SUPERNUS PHARMACEUTICALS INC USD0.001 earnings per share and revenue

0LB2 earnings per share for the last quarter are 1.17 USD whereas the estimation was 0.44 USD which accounts for 163.56% surprise. Company revenue for the same period amounts to 175.69 M USD despite the estimated figure of 157.35 M USD. Estimated earnings per share for the next quarter are 0.50 USD, and revenue is expected to reach 154.51 M USD. Also watch annual changes over time to get a bigger picture of 0LB2 earnings per share and revenue dynamics.